We are live on ! Find out more
BDSX icon

Biodesix

26 hedge funds and large institutions have $11.1M invested in Biodesix in 2025 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

92% more capital inflows, than outflows

Capital inflows: $2.93M | Capital outflows: $1.53M

40% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 5

2.53% more ownership

Funds ownership: 17.95% → 20.48% (+2.5%)

0% more funds holding

Funds holding: 26 → 26 (0)

0% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 7

Holders
26
Holders Change
–
Holders Change %
0%
% of All Funds
0.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
7
Reduced
5
Closed
7
Calls
$85K
Puts
–
Net Calls
+$85K
Net Calls Change
-$36K

BDSX Hedge Fund Activity: Q4 2025 in Review

26 of the 8,315 institutional investors tracked by Wall St. Rank reported a position in Biodesix (BDSX) for Q4 2025, worth a combined $11.1M — up 2.2% from $10.8M a quarter earlier.

Fund positioning in BDSX was balanced in Q4 2025: 7 funds opened new positions, 7 closed out, 7 added to existing stakes and 5 trimmed.

The largest buyer was Aberdeen Group, opening a new position worth an estimated $1.93M. The largest seller was Telemark Asset Management, cutting an estimated $636K.

  • 26 institutional investors held Biodesix (BDSX) as of Q4 2025, unchanged from Q3 2025.
  • Funds reported $11.1M of Biodesix stock for Q4 2025, up 2.2% quarter-over-quarter.
  • 7 funds opened new Biodesix positions in Q4 2025 and 7 closed out, a net change of 0 holders.
  • The largest Biodesix buyer in Q4 2025 was Aberdeen Group, an estimated $1.93M added.
  • The largest Biodesix seller in Q4 2025 was Telemark Asset Management, an estimated $636K sold.

Based on aggregated 13F filings for Q4 2025.